Literature DB >> 168297

A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states.

J J Morton, P L Padfield, M L Forsling.   

Abstract

A radioimmunoassay has been developed for plasma arginine-vasopressin in man and dog. The mean recovery of added arginine-vasopressin (AVP) was 60 +/-6.9 (S.D.)% and the lower threshold of detection 2.0 pmol/1. A close correlation was found between concurrent radioimmunoassay and bioassay values. The mean concentration found in peripheral venous blood in healthy men after overnight fasting was 5.3 pmol/1 (range 4.6-6.2 pmol/1.) In man, significant increases in plasma AVP occurred after dehydration (5-9-9-5 pmol/1) and significant decreases after oral water-loading (5.9-9.5 pmol/1). During i.v. infusion of graded doses of synthetic AVP in normal men, plasma levels were closely correlated with infusion rate. On stopping the infusion, plasma vasopressin fell exponentially with a half-life of between 7 and 8 min. In man, plasma AVP was unaffected by tilting head-up for 2 h, or by a non-hypotensive bleeding of 500 ml in 10 min. In the dog, haemorrhage of 5 ml/kg and over caused proportionate increases in AVP in the circulation. In normal men, plasma vasopressin was significantly correlated with concurrent urinary osmolality. Five patients with oat-cell bronchial carcinoma and hyponatraemia showed a marked increase of plasma vasopressin. Five patients with diabetes insipidus had significantly reduced, but detectable, levels of plasma AVP. The plasma concentration in these patients did not increase after water restriction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168297     DOI: 10.1677/joe.0.0650411

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  The posterior pituitary and diabetes insipidus.

Authors:  C G Beardwell
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1976

2.  Diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. 3 cases of 'DIDMOAD' syndrome.

Authors:  J E Richardson; W Hamilton
Journal:  Arch Dis Child       Date:  1977-10       Impact factor: 3.791

3.  Comparison of renal responses to 5% saline infusions into vena portae and vena cava in conscious dogs.

Authors:  F W Kapteina; W Motz; D Schwartz-Porsche; O H Gauer
Journal:  Pflugers Arch       Date:  1978-04-25       Impact factor: 3.657

4.  Pleural mesothelioma and the syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  N M Siafakas; K Tsirogiannis; B Filaditaki; F Sotsiou; M Vamvasakis
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

5.  Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction.

Authors:  P Chiodera; F Louis; J J Legros
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

6.  Glibenclamide and syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  P L Yap; A D Harrower; N M Davidson; J A Strong
Journal:  Br Med J       Date:  1977-04-30

7.  Response of antidiuretic hormone to chlorpropamide.

Authors:  M C Champion; P Padfield; J J Morton
Journal:  Br Med J       Date:  1980-09-06

8.  Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma.

Authors:  L C Rosenbaum; E A Neuwelt; H H Van Tol; Y P Loh; J G Verbalis; I Hellström; K E Hellström; G Nilaver
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

9.  Radioimmunoassay of arginine-vasopressin in human plasma: development and clinical application.

Authors:  W Hummerich; A Konrads; R Roesch; M Sofroniew
Journal:  Klin Wochenschr       Date:  1983-02-15

Review 10.  The clinical physiology of water metabolism. Part I: The physiologic regulation of arginine vasopressin secretion and thirst.

Authors:  R E Weitzman; C R Kleeman
Journal:  West J Med       Date:  1979-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.